Amendment in Export Policy of Hydroxychloroquine API and its Formulations

Notification No. 13/2015-2020 dated 18.06.2020: Amendment in Export Policy of Hydroxychloroquine API and its Formulations from ‘Prohibited’ to ‘Free’, with immediate effect.

Government of India
Ministry of Commerce & Industry
Department of Commerce
Directorate General of Foreign Trade
Udyog Bhawan
New Delhi

Notification No. 13/2015-2020

New Delhi, Dated: 18th June, 2020

Subject: – Amendment in Export Policy of Hydroxychloroquine API and its Formulations.

S.O. 1963(E).- In exercise of powers conferred by Section 3 of the Foreign Trade (Development & Regulation) Act, 1992 (No. 22 of 1992), as amended, read with Para 1.02 and 2.01 of the Foreign Trade Policy, 2015-20, the Central Government hereby makes the following amendments in the Notification No. 54 dated 25.03.2020 amending the Schedule 2 of the ITCHS Export Policy related to export of Hydroxychloroquine and its formulations, with immediate effect:

S. NoITC HS CodesDescriptionPresent PolicyRevised Policy
207 E29334900
207 F30049059
Formulations made from HydroxychloroquineProhibitedFree

2  Effect of this Notification:

The Notification No. 54 dated 25.03.2020 has been amended to change the export policy of Hydroxychloroquine API and its formulations from “Prohibited” to “Free”, with immediate effect.

(Arnit Yadav)
Director General of Foreign Trade
Ex-Officio Additional Secretary, Government of India
E-mail: [email protected]

(Issued from file No. 01/91/180/21 /AM20/EC/E-21154)